First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

528 Reviews

Credit Rating - PHARMCHEM LIMITED

ANALYSIS
Credit Risk Update: PHARMCHEM LIMITED, FIRST FLOOR, BURNELLS, 5 GARLAND ROAD, STANMORE, MIDDLESEX, HA7 1NR. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 May 2023. The company was incorporated on 24 May 1996.

The accounts next due date is 28 February 2025. There are 3 mortgages, 3 satisfied, none part satisfied and none unsatisfied.

The above was based on public record information as at 28 January 2025 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 03203602
Date Incorporated: 24 May 1996
Date Latest Accounts: 31 May 2023
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 03203602
Annual Return: 24 May 2016
Registered Office: FIRST FLOOR, BURNELLS, 5 GARLAND ROAD, STANMORE, MIDDLESEX, HA7 1NR
SIC Code and Operations: 47730
SECURED CREDITORS
Number of Mortgages 3
Satisfied Mortgages 3
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

PHARMCHEM LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 7 February 2025 Copyright © 2025 First Report Ltd


Recent Searches

Reg No. Reg Name Status
08055936 PHARMCHOICE LIMITED Active - Proposal to Strike off
12914169 PHARMCIA CONSULTING LTD Active - Proposal to Strike off
12708137 PHARMCLINIC LTD Dissolved
06181371 PHARMCO CONSULTANCY LTD Active
07488418 PHARMCO EUROPE LTD Dissolved

In using this service you agree to the Terms and Conditions

© 2025 First Report Ltd